Credit: Almirall. The expanded approval was based on data from a phase 3 safety study which evaluated tirbanibulin in more than 100 adult patients with actinic keratosis. Findings showed the safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback